DJIA 18,053.71 23.50 0.13%
NASDAQ 4,806.86 33.39 0.70%
S&P 500 2,088.77 6.89 0.33%
market minute promo


company name or ticker
Company Photos
(Click to zoom)

Actavis plc's Strong Third-Quarter Earnings Reflect Its Acquisition Bonanza

Actavis posted third-quarter earnings this morning. Here's what you need to know.

Bristol-Myers Signs Option Deal to Acquire Galecto Biotech - Analyst Blog

Key Takeaways From Teva Pharmaceutical Industries Ltd.'s Third-Quarter Earnings

Specialty and generic drugmaker Teva reported third-quarter earnings last week. Here's what you need to know.

7 Good Stocks With Return Promise

Teva Beats Q3 Earnings Expectations, Updates Outlook - Analyst Blog

Teva Beats Q3 Earnings Expectations, Updates Outlook - Analyst Blog

Investors Rewarded With Treats, Not Tricks, As Dow And S&P Close At Records High

Teva Pharmaceutical (TEVA) Earnings Report: Q3 2014 Conference Call Transcript

Is Mylan's Lively Third Quarter the Start of Something Special?

Mylan posts Street-beating top and bottom lines behind strong growth in Q3 -- and successfully completing its agreement to purchase a portion of Abbott Labs' generics business could lead to more success ahead.

Teva Pharmaceutical Industries' (TEVA) CEO Erez Vigodman on Q3 2014 Results - Earnings Call Transcri

Teva Pharmaceutical Industries' (TEVA) CEO Erez Vigodman on Q3 2014 Results - Earnings Call Transcript

Teva Pharmaceutical Industries (TEVA) Down In Pre-Market Trading

See More Articles...